Philip M. Zakas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philip M. Zakas has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Christopher B. Doering
Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University, Atlanta, GA
2 shared publicationsAnja Brehm
Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany
1 shared publication- Anum S. Kazerouni
Department of Radiology, University of Washington, Seattle, WA 98195, USA
1 shared publication - Barbara Solecka-Witulska
Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany
1 shared publication Caelan E. Radford
School of Biological Sciences, Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA; and
1 shared publicationChristine Brown
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 5 February 2021
- Published by American Society of Hematology in Blood Advances
- Vol. 5 (3) , 812-822
Molecular coevolution of coagulation factor VIII and von Willebrand factor
Ancestral sequence reconstruction provides a unique platform for investigating the molecular evolution of single gene products and recently has shown success in engineering advanced biological therapeutics. To date, the coevolution of proteins within complexes and protein–protein interactions is mostly investigated in silico via proteomics and/or within single-celled systems. Herein, ancestral sequence reconstruction is used to investigate the molecular evolution of 2 proteins linked not only by stabilizing association in circulation but also by their independent roles within the primary and secondary hemostatic systems of mammals. Using sequence analysis and biochemical characterization of recombinant ancestral von Willebrand factor (VWF) and coagulation factor VIII (FVIII), we investigated the evolution of the essential macromolecular FVIII/VWF complex. Our data support the hypothesis that these coagulation proteins coevolved throughout mammalian diversification, maintaining strong binding affinities while modulating independent and distinct hemostatic activities in diverse lineages.
- 5 February 2021
- Published by American Society of Hematology in Blood Advances
- Vol. 5 (3) , 812-822
Open AccessMolecular coevolution of coagulation factor VIII and von Willebrand factor
Ancestral sequence reconstruction provides a unique platform for investigating the molecular evolution of single gene products and recently has shown success in engineering advanced biological therapeutics. To date, the coevolution of proteins within complexes and protein–protein interactions is mostly investigated in silico via proteomics and/or within single-celled systems. Herein, ancestral sequence reconstruction is used to investigate the molecular evolution of 2 proteins linked not only by stabilizing association in circulation but also by their independent roles within the primary and secondary hemostatic systems of mammals. Using sequence analysis and biochemical characterization of recombinant ancestral von Willebrand factor (VWF) and coagulation factor VIII (FVIII), we investigated the evolution of the essential macromolecular FVIII/VWF complex. Our data support the hypothesis that these coagulation proteins coevolved throughout mammalian diversification, maintaining strong binding affinities while modulating independent and distinct hemostatic activities in diverse lineages.
- Open Access
- 27 September 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 12863
Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor
Mechanisms by which blood cells sense shear stress are poorly characterized. In platelets, glycoprotein (GP)Ib–IX receptor complex has been long suggested to be a shear sensor and receptor. Recently, a relatively unstable and mechanosensitive domain in the GPIbα subunit of GPIb–IX was identified. Here we show that binding of its ligand, von Willebrand factor, under physiological shear stress induces unfolding of this mechanosensory domain (MSD) on the platelet surface. The unfolded MSD, particularly the juxtamembrane ‘Trigger’ sequence therein, leads to intracellular signalling and rapid platelet clearance. These results illustrate the initial molecular event underlying platelet shear sensing and provide a mechanism linking GPIb–IX to platelet clearance. Our results have implications on the mechanism of platelet activation, and on the pathophysiology of von Willebrand disease and related thrombocytopenic disorders. The mechanosensation via receptor unfolding may be applicable for many other cell adhesion receptors.
- 27 September 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 12863
Open AccessPlatelet clearance via shear-induced unfolding of a membrane mechanoreceptor
Mechanisms by which blood cells sense shear stress are poorly characterized. In platelets, glycoprotein (GP)Ib–IX receptor complex has been long suggested to be a shear sensor and receptor. Recently, a relatively unstable and mechanosensitive domain in the GPIbα subunit of GPIb–IX was identified. Here we show that binding of its ligand, von Willebrand factor, under physiological shear stress induces unfolding of this mechanosensory domain (MSD) on the platelet surface. The unfolded MSD, particularly the juxtamembrane ‘Trigger’ sequence therein, leads to intracellular signalling and rapid platelet clearance. These results illustrate the initial molecular event underlying platelet shear sensing and provide a mechanism linking GPIb–IX to platelet clearance. Our results have implications on the mechanism of platelet activation, and on the pathophysiology of von Willebrand disease and related thrombocytopenic disorders. The mechanosensation via receptor unfolding may be applicable for many other cell adhesion receptors.
- Open Access
- 26 September 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (1) , 35-37
Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction
The pharmaceutical properties of coagulation factor VIII are improved by reconstructing the protein's ancestral sequence. Optimization of a protein's pharmaceutical properties is usually carried out by rational design and/or directed evolution. Here we test an alternative approach based on ancestral sequence reconstruction. Using available genomic sequence data on coagulation factor VIII and predictive models of molecular evolution, we engineer protein variants with improved activity, stability, and biosynthesis potential and reduced inhibition by anti-drug antibodies. In principle, this approach can be applied to any protein drug based on a conserved gene sequence.
- 26 September 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (1) , 35-37
Open AccessEnhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction
The pharmaceutical properties of coagulation factor VIII are improved by reconstructing the protein's ancestral sequence. Optimization of a protein's pharmaceutical properties is usually carried out by rational design and/or directed evolution. Here we test an alternative approach based on ancestral sequence reconstruction. Using available genomic sequence data on coagulation factor VIII and predictive models of molecular evolution, we engineer protein variants with improved activity, stability, and biosynthesis potential and reduced inhibition by anti-drug antibodies. In principle, this approach can be applied to any protein drug based on a conserved gene sequence.